FeelBetter has developed an AI-based Pharmaco-Clinical Intelligence platform with four core tools: Insight (risk stratification), Navigator (workflow management), Action (AI decision-support for pharmacists) and Impact (post-intervention monitoring). The company reports reaching more than 300,000 patients daily and cites partnerships with Leumit HMO, Atlantic Health, and a retrospective study at Brigham & Women’s Hospital validating its outcomes. Published and partner-reported results include large reductions in hospital admissions and days, clinical improvements in LDL and HbA1c, a 5x increase in pharmacist capacity reported by Leumit, and estimated cost savings per high-risk patient. FeelBetter has raised $11.5 million from grants and investors to date and is actively seeking Series A funding. The firm says it is expanding its global footprint and plans to partner with more U.S.-based health systems to pursue broader adoption of its population- and individual-level solution.

Total raised

$12M

Funding rounds

1

Latest round

Equity

Latest activity

Oct 2024